IL125075A - Penciclovir or famciclovir in combination with immunosuppressants in the treatment of herpes simplex virus infections - Google Patents

Penciclovir or famciclovir in combination with immunosuppressants in the treatment of herpes simplex virus infections

Info

Publication number
IL125075A
IL125075A IL12507597A IL12507597A IL125075A IL 125075 A IL125075 A IL 125075A IL 12507597 A IL12507597 A IL 12507597A IL 12507597 A IL12507597 A IL 12507597A IL 125075 A IL125075 A IL 125075A
Authority
IL
Israel
Prior art keywords
penciclovir
famciclovir
immunosuppressants
treatment
combination
Prior art date
Application number
IL12507597A
Other languages
English (en)
Other versions
IL125075A0 (en
Original Assignee
Novartis Int Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10787583&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL125075(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Int Pharm Ltd filed Critical Novartis Int Pharm Ltd
Publication of IL125075A0 publication Critical patent/IL125075A0/xx
Publication of IL125075A publication Critical patent/IL125075A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL12507597A 1996-01-26 1997-01-24 Penciclovir or famciclovir in combination with immunosuppressants in the treatment of herpes simplex virus infections IL125075A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9601544.1A GB9601544D0 (en) 1996-01-26 1996-01-26 Pharmaceuticals
PCT/GB1997/000226 WO1997026882A1 (en) 1996-01-26 1997-01-24 Nucleoside analogs in combination therapy of herpes simplex infections

Publications (2)

Publication Number Publication Date
IL125075A0 IL125075A0 (en) 1999-01-26
IL125075A true IL125075A (en) 2003-02-12

Family

ID=10787583

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12507597A IL125075A (en) 1996-01-26 1997-01-24 Penciclovir or famciclovir in combination with immunosuppressants in the treatment of herpes simplex virus infections

Country Status (26)

Country Link
US (5) US6514980B1 (no)
EP (1) EP0876146B1 (no)
JP (1) JP2000507211A (no)
KR (1) KR19990081966A (no)
CN (1) CN1133433C (no)
AR (1) AR005551A1 (no)
AT (1) ATE238796T1 (no)
AU (1) AU713202B2 (no)
BR (1) BR9707304A (no)
CY (1) CY2421B1 (no)
CZ (1) CZ297841B6 (no)
DE (1) DE69721484T2 (no)
DK (1) DK0876146T3 (no)
ES (1) ES2199339T3 (no)
GB (1) GB9601544D0 (no)
HK (1) HK1016475A1 (no)
HU (1) HU226793B1 (no)
IL (1) IL125075A (no)
NO (1) NO316355B1 (no)
NZ (1) NZ326839A (no)
PL (1) PL187076B1 (no)
PT (1) PT876146E (no)
TR (1) TR199801439T2 (no)
TW (1) TW493985B (no)
WO (1) WO1997026882A1 (no)
ZA (1) ZA97608B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW438585B (en) 1995-02-06 2001-06-07 Astra Ab Pharmaceutical compositions for topical administration for prophylaxis and/or treatment of herpesvirus infections
GB9601544D0 (en) * 1996-01-26 1996-03-27 Smithkline Beecham Plc Pharmaceuticals
US7591945B2 (en) * 2003-02-07 2009-09-22 Gambro Lundia Ab Support device for containers in extracorporeal blood treatment machines
CA2602562C (en) * 2005-03-25 2015-07-07 Alt Solutions, Inc. Modulation of telomere length in telomerase positive cells and cancer therapy
WO2006125166A2 (en) * 2005-05-18 2006-11-23 Alt Solutions, Inc. Pharmacological modulation of telomere length in cancer cells for prevention and treatment of cancer
WO2011035120A2 (en) * 2009-09-17 2011-03-24 Gk Ventures, L.L.C. Therapeutic composition to treat lesions caused by herpes simplex virus
GB201907305D0 (en) * 2019-05-23 2019-07-10 Douglas Pharmaceuticals Ltd Treatment of conditions
CN112704154A (zh) * 2020-12-24 2021-04-27 中国人民解放军66399部队 一种用于治疗宠物猫疱疹病毒的营养膏

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3317384A (en) * 1964-06-08 1967-05-02 Upjohn Co Treatment of topical viral infections with glucocorticoids and nucleosides
US3322627A (en) * 1964-09-03 1967-05-30 Merck & Co Inc Method of treating herpes simplex infections with 5-methylamino-2'-deoxyuridine, and compositions therefor
GB9001886D0 (en) * 1990-01-26 1990-03-28 Beecham Group Plc Pharmaceutical formulation
GB9015051D0 (en) * 1990-07-07 1990-08-29 Beecham Group Plc Pharmaceutical treatment
ATE146075T1 (de) 1992-10-01 1996-12-15 Wellcome Found Tucaresol als mittel zur immunopotentierung
GB9426021D0 (en) 1994-12-22 1995-02-22 Smithkline Beecham Plc Pharmaceuticals
TW438585B (en) * 1995-02-06 2001-06-07 Astra Ab Pharmaceutical compositions for topical administration for prophylaxis and/or treatment of herpesvirus infections
GB9601544D0 (en) * 1996-01-26 1996-03-27 Smithkline Beecham Plc Pharmaceuticals
US6136835A (en) * 1999-05-17 2000-10-24 The Procter & Gamble Company Methods of treatment for viral infections

Also Published As

Publication number Publication date
NO983402L (no) 1998-07-23
US20050222016A1 (en) 2005-10-06
ZA97608B (en) 1998-07-24
CN1209748A (zh) 1999-03-03
WO1997026882A1 (en) 1997-07-31
CZ297841B6 (cs) 2007-04-11
CZ234098A3 (cs) 1999-02-17
NO983402D0 (no) 1998-07-23
BR9707304A (pt) 1999-07-20
PL327917A1 (en) 1999-01-04
EP0876146A1 (en) 1998-11-11
TR199801439T2 (xx) 1998-10-21
PL187076B1 (pl) 2004-05-31
EP0876146B1 (en) 2003-05-02
DK0876146T3 (da) 2003-08-11
DE69721484D1 (de) 2003-06-05
GB9601544D0 (en) 1996-03-27
DE69721484T2 (de) 2004-02-26
HUP9900945A3 (en) 2001-02-28
CY2421B1 (en) 2004-11-12
AU1550697A (en) 1997-08-20
HUP9900945A2 (hu) 1999-07-28
PT876146E (pt) 2003-09-30
US20080287389A1 (en) 2008-11-20
CN1133433C (zh) 2004-01-07
JP2000507211A (ja) 2000-06-13
IL125075A0 (en) 1999-01-26
NO316355B1 (no) 2004-01-19
NZ326839A (en) 2001-02-23
ATE238796T1 (de) 2003-05-15
US6514980B1 (en) 2003-02-04
KR19990081966A (ko) 1999-11-15
AU713202B2 (en) 1999-11-25
AR005551A1 (es) 1999-06-23
US20040185433A1 (en) 2004-09-23
HU226793B1 (en) 2009-10-28
ES2199339T3 (es) 2004-02-16
TW493985B (en) 2002-07-11
HK1016475A1 (en) 1999-11-05
US20100323952A1 (en) 2010-12-23

Similar Documents

Publication Publication Date Title
ZA9710339B (en) Xanthines and their therapeutic use
HK1052693A1 (zh) 吡咯並三嗪和嘧啶化合物
LT99008A (en) Azolo triazines and pyrimidines
AU4289100A (en) Dihydropyrimidines and their use in the treatment of hepatitis
GR3024699T3 (en) Use of dideoxy nucleoside analogues in the treatment of viral infections.
IL113409A (en) Preparation of famciclovir and penciclovir
ZA975288B (en) The use of TCET in the prophylaxis and treatment of allergies.
IL125075A (en) Penciclovir or famciclovir in combination with immunosuppressants in the treatment of herpes simplex virus infections
GB2340491B (en) Carbocyclic nucleoside hemisulfate and its use in treating viral infections
EP0797440A4 (en) TREATING AUTOIMMUNE DISEASES WITH THE AID OF 2-AMINOPURINE DERIVATIVES
AU6748090A (en) Use of caffeine in the treatment of herpes simplex virus infections
HK1004527A1 (en) Penciclovir and famciclovir and related guanine derivatives for the treatment of the hiv-1 infections
IL127871A0 (en) Azolo triazines and pyrimidines
CY2339B1 (en) Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections.
GB9317915D0 (en) Tableware and other utensils for the disabled
EP0630897A3 (en) 3-hydroxy-4-hydroxymethyl-2-methylene-cyclopentyl purines and pyrimidines.
GB9603657D0 (en) Improvements in the treatment of vaginal infections
SI0876146T1 (en) Nucleoside analogs in combination therapy of herpes simplex infections
AU1436901A (en) Treatment and prevention of herpes simplex infections
LV10385B (en) Use of quinons in the treatment of cancer or aids
IL150163A0 (en) Azolo triazines and pyrimidines
CA2244268A1 (en) Nucleoside analogs in combination therapy of herpes simplex infections
NZ314730A (en) Use of dideoxycytosine derivatives in the treatment of viral infection

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees